Session Information

  • WCLC 2021

    2021 World Conference on Lung Cancer

    Presentation Date(s):  
    • September 8 - 14, 2021
    • Total Presentations: 1107

    All times listed are in Mountain Time MDT (UTC-6:00)

    PL - Plenary
    ES - Education Session
    OA - Oral Session
    MA - Mini Oral Session
    FP - Featured Posters
    P - Posters
    WS - Workshops
    IS - Industry Symposium
    MTE - Meet the Expert
    BEDG - Brain Exchange Discussion Groups

Filter Results:

Show Only CME Accredited Sessions

  • +

    P29 - Locally Advanced Non-Small Cell Lung Cancer - Radiation Planning and Delivery

    • 00:00 - 00:00
    • 9/08/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Locally Advanced Non-Small Cell Lung Cancer
    • +

      P29.03 - Thoracic Organs at Risk (OARs) Contouring Variations and Consensus in Radiation Therapy for Non-Small Cell Lung Cancer

      00:00 - 00:00  |  Presenter: Feng Ming Spring Kong

      • Abstract

      Loading...

    • +

      P29.05 - Gross Tumor Volume Contouring Variations in Radiation Therapy of Non-Small Cell Lung Cancer

      00:00 - 00:00  |  Presenter: Feng Ming Spring Kong

      • Abstract

      Loading...

  • +

    P47 - Novel Therapeutics and Targeted Therapies - Clinical Trial in Progress

    • 00:00 - 00:00
    • 9/08/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Novel Therapeutics and Targeted Therapies
    • +

      P47.18 - Almonertinib With Radiotherapy vs Concurrent Chemoradiotherapy in Unresectable Stage III EGFR-mutant NSCLC (ADVANCE Trial)

      00:00 - 00:00  |  Presenter: Nan Bi

      • Abstract

      Loading...

  • +

    P64 - Small Cell Lung Cancer/ NET - Clinical Trial in Progress

    • 00:00 - 00:00
    • 9/08/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Small Cell Lung Cancer/ NET
    • +

      P64.04 - Hypo-Fractionated Versus Conventionally Fractionated Radiotherapy for Patients with LS-SCLC: An Open-Label, Randomized, Phase 3 Trial

      00:00 - 00:00  |  Presenter: Nan Bi

      • Abstract

      Loading...